Shockwave Medical's Structural Shift Following Major Merger
News On Shockwave Medical Inc. (SWAV) Now Under JNJ
News On Shockwave Medical Inc. (SWAV) Now Under JNJ
Sector Update: Health Care Stocks Higher Late Afternoon
Health care stocks were higher late Friday afternoon, with the NYSE Health Care Index advancing 0.9% and the Health Care Select Sector SPDR Fund (XLV) up 0.8%. The iShares Biotechnology ETF (IBB) adde
Johnson & Johnson: Shockwave Medical Will Operate as a Business Unit Within Johnson & Johnson MedTech >JNJ
Johnson & Johnson: Shockwave Medical Will Operate as a Business Unit Within Johnson & Johnson MedTech >JNJ
Express News | Johnson & Johnson Completes Acquisition of Shockwave Medical
Why Sarepta Therapeutics Stock Is Rising Today
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stock is trading higher on Thursday after it was announced the company will be added to the S&P MidCap 400.What Happened: Effective prior to the opening of tra
Sector Update: Health Care
Health care stocks were mixed pre-bell Thursday, with the Health Care Select Sector SPDR Fund (XLV) up 0.1% and the iShares Biotechnology ETF (IBB) declining 0.1%. Sarepta Therapeutics (SRPT) shares r
Here's Why Shockwave Medical (SWAV) Surged in Q1
Sarepta Therapeutics to Replace Shockwave Medical in S&P MidCap 400
Sarepta Therapeutics (SRPT) is set to replace Shockwave Medical (SWAV) in the S&P MidCap 400 effective June 3, according to a late Wednesday statement from S&P Dow Jones Indices. Johnson & Johnson (JN
Express News | Sarepta Therapeutics Set to Join S&P MidCap 400
Sarepta Therapeutics To Join S&P Midcap 400, Effective June 3
Sarepta Therapeutics will replace Shockwave Medical in the S&P MidCap 400 effective prior to the opening of trading on Monday, June 3. S&P 500 constituent Johnson & Johnson is acquiring Shockwave Medi
Top Gap Ups and Downs on Wednesday: ADI, TJX, SCCO and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Shockwave Medical Gains After HSR Waiting Period for Sale to J&J Expires
Express News | Shockwave Medical Inc: Expiration of Waiting Period Under Hsr Act Satisfies One of Conditions to Closing of Merger
Express News | Shockwave Medical: Required Waiting Period Under Hsr Act With Respect to Merger With Johnson & Johnson Expired at 11:59 P.m., Eastern Time on May 20
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Thursday, Johnson & Johnson (NYSE:JNJ) agreed to acquire Proteologix Inc., a privately held biotechnology company focused on bispecific antibodies for immune-mediated diseases, for $850 million in cas
J&J Scores Lowest Spread of Year on Bonds to Help Fund $13 Billion Bid for Shockwave
By Joy Wiltermuth Wall Street deal-making remains robust despite the Federal Reserve's rate hikes since 2022 Johnson & Johnson sailed through the market on Monday, with a four-part bond to help fund
J&J's $13 Billion Bid for Shockwave Turns to Wall Street for Funding
By Joy Wiltermuth Wall Street deal making remains robust despite the Federal Reserve's rate hikes since 2022 Johnson & Johnson (JNJ) rolled out a four-part bond on Monday to help fund its planned $1
Johnson & Johnson Offering Notes to Help Fund Shockwave Medical Acquisition
Johnson & Johnson (JNJ) said Monday it is offering its senior unsecured notes in four tranches to help fund its planned acquisition of Shockwave Medical (SWAV). Closing of the deal is subject to appro
Maintaining Hold: Shockwave Medical's Solid Performance Tempered by Market Valuation
No Data